OneSource Specialty Pharma Ltd - Onesource Specialty Pharma Limited - Reply to Clarification- Financial results
(08 Jul 2025)

Back
The Exchange had sought clarification from Onesource Specialty Pharma Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Limited Review Report/ Independent Auditors Report is not in the format prescribed by SEBI The response of the Company is enclosed.

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew